Who
Marc H. Hedrick
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Cerenome.
In numbers
- Trades disclosed
- 146
- Buys
- 30
- Sells
- 1
- Bought
- $383K
- Sold
- $4,053
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Jan 2006
- Last trade
- 1 Oct 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 1 Oct 2026 | CNSY CerenomeMedical Devices | SEC FORM 4 Code M | —6,387 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY CerenomeMedical Devices | SEC FORM 4 Code M | —8,066 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY CerenomeMedical Devices | SEC FORM 4 Code M | —1,986 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY Cerenomeoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,387 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY Cerenomeoption or derivative · Medical Devices | SEC FORM 4 Code M | —8,066 at $0.00 | filing |
| 1 Oct 2026filed 1 Oct 2026 | CNSY Cerenomeoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,986 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —6,387 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —8,066 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —1,986 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,387 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —8,066 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,986 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —6,387 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —8,066 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,986 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —6,387 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —8,066 at $0.00 | filing |
| 1 Jul 2026filed 1 Jul 2026 | Plus TherapeuticsMedical Devices | SEC FORM 4 Code M | —1,986 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,834 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | Plus Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | —23,834 at $0.00 | filing |
News
Cerenome Secures In-Network Agreement with Florida Blue for CNSide® CSF Tumor Cell Enumeration and Molecular Profile TestsCNSY · manilatimes.net · 8 Oct 2026Cerenome Launches CNSide® CSF Molecular Profile TestsCNSY · manilatimes.net · 6 Oct 2026
0 headlines in the last 90 days name Marc H. Hedrick; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.